News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Suzanne Lentzsch: Prevalence of MGUS in Africa
Photo taken from Suzanne Lentzsch/X
Jul 16, 2024, 02:40

Suzanne Lentzsch: Prevalence of MGUS in Africa

Suzanne Lentzsch, Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University, shared on X:

“Prevalence of MGUS in Africa: a Population-Based study by⁦⁦ Herbert Irving Comprehensive Cancer Center⁩ team our study suggests incidence of MGUS is similar between ethnicities higher light-chain MGUS might reflect alternate etiologies, such as untreated HIV infection.”

‘Prevalence of monoclonal gammopathy of undetermined significance in eswatini: a Population-Based study in africa’ Published in JNCI Cancer Spectrum

Autors: Kara I Cicero, Xolisile Dlamini, Yvonne Mavengere, Jessica Justman, Harriet Nuwagaba-Biribonwoha, Sindisiwe Dlamini, Mxolisi Dlamini, Simphiwe Ngwenyama, Cebisile Ngcamphalala, Andrea Low, Neena M Philip, Wafaa M El-Sadr,  Ruben Sahabo, Tesfay Abreha, Sintayehu Temesgen, Nokuthula Mahlalela, Codruta Chiuzan, Yuxuan Chen, Samuel S Pan, Suzanne Lentzsch, Alfred I Neugut.

 

Suzanne Lentzsch: Prevalence of MGUS in Africa

Source: Suzanne Lentzsch/X

Alfred I Neugut Andrea Low cancer Cebisile Ngcamphalala Codruta Chiuzan Harriet Nuwagaba-Biribonwoha Herbert Irving Comprehensive Cancer Center⁩ HIV infection Jessica Justman Kara I Cicero Mxolisi Dlamini Neena M Philip Nokuthula Mahlalela OncoDaily Oncology Ruben Sahabo Samuel S Pan Simphiwe Ngwenyama Sindisiwe Dlamini Sintayehu Temesgen Suzanne Lentzsch Tesfay Abreha Wafaa M El-Sadr Xolisile Dlamini Yuxuan Chen Yvonne Mavengere
Special Coverage
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress